Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

20.47
Delayed Data
As of 3:59pm ET
 -0.15 / -0.73%
Today’s Change
15.15
Today|||52-Week Range
35.35
+22.80%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close20.62
Today’s open20.68
Day’s range20.43 - 20.78
Volume654,280
Average volume (3 months)1,484,945
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)+58.33%
Earnings growth (this year)-37.55%
Earnings growth (next 5 years)-3.70%
Revenue growth (last year)+4.25%
P/E ratio45.5
Price/Sales2.98
Price/Book1.90

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...+0.19+0.50%
IMMUImmunomedics Inc-0.08-1.06%
QDELQuidel Corp+0.01+0.04%
--Quidel Corp+0.16+0.75%
Data as of 4:00pm ET, 05/24/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)$0.27
Annual revenue (last year)$753.8M
Annual profit (last year)$125.3M
Net profit margin16.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts